Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations

The purpose of this bill is to permit lawful prescription, distribution, and marketing of any composition of crystalline polymorph psilocybin that the United States Food and Drug Administration approves and that is rescheduled by the United States Drug Enforcement Administration, in accordance with the recommendations of the United States Food and Drug Administration.

Source: OpenStates · fetched March 27, 2026

• WV HB4089Preservation of hair during chemotherapy. Also known as the “Jessica Huffman Bill”
• WV HB4169Relating to mental health examination requirements.
• WV HB5437Creating the Vape Safety Act
• WV SB897Relating to licensure and certification of alcohol and drug counselors
• WV HB5004Relating generally to PANS and PANDAS.